Related Experiment Video

Updated: Mar 13, 2026

In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues
10:36

In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues

Published on: March 21, 2017

8.1K

LHRH-Targeted Drug Delivery Systems for Cancer Therapy

Xiaoning Li, Oleh Taratula1, Olena Taratula

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201,. United States.

Mini Reviews in Medicinal Chemistry
|October 15, 2016
PubMed

Insights

Targeted cancer therapy uses luteinizing hormone-releasing hormone (LHRH) peptides to deliver drugs directly to tumors. This approach enhances treatment efficacy and minimizes side effects by targeting LHRH receptors overexpressed on cancer cells.

Area of Science:

  • Oncology
  • Nanotechnology
  • Pharmacology

Background:

  • Targeted drug delivery aims to improve cancer treatment outcomes and reduce side effects.
  • Overexpressed cell surface receptors on cancer cells offer targets for selective drug delivery.
  • Luteinizing hormone-releasing hormone (LHRH) receptors are prevalent in many cancers with limited expression in healthy tissues.

Purpose of the Study:

  • To provide an overview of targeted drug delivery platforms utilizing LHRH receptor overexpression.
  • To highlight the potential of LHRH peptides in guiding therapeutic and diagnostic agents to cancer sites.

Main Methods:

  • Review of recent studies on LHRH-targeted drug delivery systems.
  • Analysis of LHRH receptor expression patterns in cancerous and healthy tissues.
  • Exploration of platforms designed for targeted delivery of anticancer and imaging agents.

Main Results:

  • LHRH peptides can efficiently direct anticancer and imaging agents to cancer cells.
  • Targeting LHRH receptors increases agent accumulation in tumor tissue.
  • This strategy minimizes exposure of normal cells to therapeutic agents.

Conclusions:

  • LHRH receptor-targeted drug delivery is a promising strategy for enhancing cancer therapy.
  • This approach holds potential for both therapeutic and diagnostic applications in oncology.
  • Further development of LHRH-based delivery systems could significantly advance cancer treatment.

More Related Videos

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

8.1K
Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.5K

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
70
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
79
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
163
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
167